2026: reflecting on the last year’s research progress and looking at what’s ahead
2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much...
Learn more
Cure Parkinson’s welcomes Rory Cellan-Jones as new patron
Cure Parkinson’s is delighted to announce that Rory Cellan-Jones, former technology correspondent for the BBC, writer, ‘Movers & Shakers’ podcaster, technology advisor and owner of one the UK’s most beloved rescue dogs, has joined Cure Parkinson’s as a patron. Rory was diagnosed with Parkinson’s in…
Cure Parkinson’s welcomes five new trustees
Cure Parkinson’s has grown rapidly in recent years, influencing and funding increasingly larger projects with the goal of moving the research forward faster than ever. As part of our growth it’s important to expand our board of trustees, to add new expertise and fresh perspective,…
Dr Richard Wyse named in His Majesty The King’s New Year’s Honours List
Dr. Richard Wyse, Cure Parkinson’s Director of Clinical Development, has been recognised with a prestigious inclusion in His Majesty The King’s New Year’s Honours List, for services to medicine in Parkinson’s disease.
The Big Give Christmas Challenge 2023
The Big Give Christmas Challenge is the UK’s biggest match-funded campaign and Cure Parkinson’s is delighted to have been chosen as one of the beneficiaries of this year’s campaign.